Cancer 
        Digest        

A new large-scale analysis of older adults with advanced cancer reveals a stark "preference gap" in modern oncology, showing that clinical treatments rarely align with what patients actually value most.

Targeted therapies that have pushed significantly higher survival rates for colorectal cancer, gastric cancer, liver cancer, and gastrointestinal stromal tumors, may have unrecognized long-term toxic side effects, according to an international group of researchers.

After two years, patients receiving gemcitabine and Elenagen survived twice as long as those treated with chemotherapy alone.

Most American women prefer to have their cervical cancer screening done by a professional in a doctor’s office despite the availability of newly FDA-approved at-home screening kits.

Metastatic melanoma cells – Image Credit National Cancer Institute CANCER DIGEST – Jan. 24, 2026 – When a personalized mRNA cancer vaccine is added to an immunotherapy for the treatment of advanced melanoma, more patients survived without recurrence than those treated with pembrolizumab (Keytruda®) alone, the five-year updated results of a clinical trial show. The KEYNOTE-942 ongoing clinical trial ( NCT03897881 ) compares the effectiveness of treatment of patients with stage

Individually-tailored risk-based screening may be a more efficient way to screen for breast cancer. Image credit – National Cancer Institute CANCER DIGEST – Jan. 18, 2026 – Tailoring breast cancer screening to individual risk factors as opposed to relying on age guidelines may be a better way to reduce the chance of advanced cancer at diagnosis, a major screening study shows. The WISDOM study enrolled 46,000 women from all 50 states between 2016 and 2023. The aim was to compa